Difference between revisions of "Graft versus host disease"
Jump to navigation
Jump to search
m (→References) |
|||
Line 21: | Line 21: | ||
*Stage 4: Severe abdominal pain, with or without ileus | *Stage 4: Severe abdominal pain, with or without ileus | ||
− | === | + | ===Glucksberg grade=== |
{| border="1" | {| border="1" | ||
Line 56: | Line 56: | ||
|} | |} | ||
+ | ===IBMTR severity index=== | ||
+ | |||
+ | {| border="1" | ||
+ | !Overall grade | ||
+ | !I | ||
+ | !II | ||
+ | !III | ||
+ | !IV | ||
+ | |- | ||
+ | |Skin | ||
+ | |1-2 | ||
+ | |1-3 | ||
+ | |2-3 | ||
+ | |2-4 | ||
+ | |- | ||
+ | |GI | ||
+ | |0 | ||
+ | |1 | ||
+ | |2-3 | ||
+ | |2-4 | ||
+ | |- | ||
+ | |Liver | ||
+ | |0 | ||
+ | |1 | ||
+ | |2-4 | ||
+ | |2-4 | ||
+ | |- | ||
+ | |Karnofsky performance scale | ||
+ | |90-100% | ||
+ | |70-80% | ||
+ | |50-60% | ||
+ | |30-40% | ||
+ | |- | ||
+ | |} | ||
==Chronic GVHD== | ==Chronic GVHD== | ||
===Localized=== | ===Localized=== |
Revision as of 22:07, 26 November 2011
Glucksberg acute graft versus host (GVHD) scores
Skin
- Stage 0: No rash
- Stage 1: Maculopapular rash <25% of body surface area
- Stage 2: Maculopapular rash on 25-50% of body surface area
- Stage 3: Generalized erythroderma
- Stage 4: Generalized erythroderma with bullous formation and desquamation
Liver
- Stage 0: Bilirubin <2 mg/dL
- Stage 1: Bilirubin 2-3 mg/dL
- Stage 2: Bilirubin 3.01-6 mg/dL
- Stage 3: Bilirubin 6.01-15.0 mg/dL
- Stage 4: Bilirubin >15 mg/dL
GI
- Stage 0: No diarrhea, or diarrhea <500 mL/day
- Stage 1: Diarrhea 500-999 mL/day
- Stage 2: Diarrhea 1000-1499 mL/day
- Stage 3: Diarrhea >1500 mL/day
- Stage 4: Severe abdominal pain, with or without ileus
Glucksberg grade
Overall grade | I | II | III | IV |
---|---|---|---|---|
Skin | 1-2 | 1-3 | 2-3 | 2-4 |
GI | 0 | 1 | 2-3 | 2-4 |
Liver | 0 | 1 | 2-4 | 2-4 |
Karnofsky performance scale | 90-100% | 70-80% | 50-60% | 30-40% |
IBMTR severity index
Overall grade | I | II | III | IV |
---|---|---|---|---|
Skin | 1-2 | 1-3 | 2-3 | 2-4 |
GI | 0 | 1 | 2-3 | 2-4 |
Liver | 0 | 1 | 2-4 | 2-4 |
Karnofsky performance scale | 90-100% | 70-80% | 50-60% | 30-40% |
Chronic GVHD
Localized
- Localized skin and/or liver dysfunction due to chronic GVHD
Extensive
- Generalized skin involvement or localized skin and/or liver dysfunction due to chronic GVHD plus at least one of the following:
- Liver biopsy showing cirrhosis, chronic aggressive hepatitis, bridging necrosis
- Eye involvement, defined as Schirmer's test with <5 mm wetting
- Involvement of oral mucosa on lip biopsy or minor salivary glands
- Other organ involvement
- Overall severity categories: mild/moderate/severe
References
- Thomas E, Storb R, Clift RA, Fefer A, Johnson FL, Neiman PE, Lerner KG, Glucksberg H, Buckner CD. Bone-marrow transplantation (first of two parts). N Engl J Med. 1975 Apr 17;292(16):832-43 link to original article PubMed
- Thomas ED, Storb R, Clift RA, Fefer A, Johnson L, Neiman PE, Lerner KG, Glucksberg H, Buckner CD. Bone-marrow transplantation (second of two parts). N Engl J Med. 1975 Apr 24;292(17):895-902 link to original article (contains staging scale) PubMed
- Rowlings PA, Przepiorka D, Klein JP, Gale RP, Passweg JR, Henslee-Downey PJ, Cahn JY, Calderwood S, Gratwohl A, Socié G, Abecasis MM, Sobocinski KA, Zhang MJ, Horowitz MM. IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade. Br J Haematol. 1997 Jun;97(4):855-64. link to original article PubMed